Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1059)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,638
Price
$563.68
Total Value
$923.31K
Shares Held After
46,560
% of Holdings
3.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,520
Price
$562.59
Total Value
$855.13K
Shares Held After
48,198
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
295
Price
$561.53
Total Value
$165.65K
Shares Held After
49,718
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
228
Price
$571.48
Total Value
$130.30K
Shares Held After
18,876
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
332
Price
$570.50
Total Value
$189.40K
Shares Held After
19,104
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
844
Price
$568.90
Total Value
$480.15K
Shares Held After
19,436
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,605
Price
$567.91
Total Value
$911.50K
Shares Held After
20,280
% of Holdings
7.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
934
Price
$566.87
Total Value
$529.45K
Shares Held After
21,885
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
893
Price
$566.00
Total Value
$505.43K
Shares Held After
22,819
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,208
Price
$564.82
Total Value
$682.30K
Shares Held After
23,712
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,675
Price
$563.87
Total Value
$944.49K
Shares Held After
24,920
% of Holdings
6.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,961
Price
$562.77
Total Value
$1.10M
Shares Held After
26,595
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
320
Price
$561.48
Total Value
$179.67K
Shares Held After
28,556
% of Holdings
1.1%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
148
Price
$32.67
Total Value
$4.84K
Shares Held After
833,694
% of Holdings
0.0%
Eton Pharmaceuticals, Inc. (ETON)
BRYNJELSEN SEAN — Director
Shares
119,852
Price
$31.88
Total Value
$3.82M
Shares Held After
833,842
% of Holdings
12.6%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,989
Price
$4.93
Total Value
$14.74K
Shares Held After
182,161
% of Holdings
1.6%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
101
Price
$44.49
Total Value
$4.49K
Shares Held After
2,671,721
% of Holdings
0.0%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
101
Price
$44.49
Total Value
$4.49K
Shares Held After
2,671,721
% of Holdings
0.0%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
80,852
Price
$0.48
Total Value
$38.81K
Shares Held After
682,833
% of Holdings
10.6%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
20,425
Price
$66.16
Total Value
$1.35M
Shares Held After
8,977
% of Holdings
69.5%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
54,575
Price
$65.37
Total Value
$3.57M
Shares Held After
29,402
% of Holdings
65.0%
Equillium, Inc. (EQ)
Zedelmayer Christine — Sr. Vice President and COO
Shares
9,821
Price
$2.70
Total Value
$26.52K
Shares Held After
62,586
% of Holdings
13.6%
CORCEPT THERAPEUTICS INC (CORT)
Lyon Joseph Douglas — Chief Accounting & Technology Officer
Shares
5,000
Price
$65.00
Total Value
$325.00K
Shares Held After
6,230
% of Holdings
44.5%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
33,800
Price
$26.78
Total Value
$905.22K
Shares Held After
229,918
% of Holdings
12.8%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
2,000
Price
$2.00
Total Value
$4.00K
Shares Held After
5,529
% of Holdings
36.2%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
4,500
Price
$1.07
Total Value
$4.82K
Shares Held After
62,514
% of Holdings
7.2%
Monte Rosa Therapeutics, Inc. (GLUE)
Champoux Jennifer — Chief Operating Officer
Shares
2,175
Price
$20.00
Total Value
$43.50K
Shares Held After
62,371
% of Holdings
3.4%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
6,400
Price
$7.91
Total Value
$50.62K
Shares Held After
520,284
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$579.59
Total Value
$46.37K
Shares Held After
40,513
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,695
Price
$578.22
Total Value
$980.08K
Shares Held After
40,593
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,756
Price
$577.24
Total Value
$1.01M
Shares Held After
42,288
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,469
Price
$576.23
Total Value
$1.42M
Shares Held After
44,044
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$575.50
Total Value
$391.34K
Shares Held After
46,513
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$574.23
Total Value
$252.66K
Shares Held After
47,193
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$572.45
Total Value
$183.18K
Shares Held After
47,633
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
581
Price
$571.55
Total Value
$332.07K
Shares Held After
47,953
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,479
Price
$570.81
Total Value
$844.23K
Shares Held After
48,534
% of Holdings
3.0%
aTYR PHARMA INC (ATYR)
SCHIMMEL PAUL — Director
Shares
100,000
Price
$0.50
Total Value
$49.63K
Shares Held After
779,143
% of Holdings
12.8%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$77.21
Total Value
$579.08K
Shares Held After
392,830
% of Holdings
1.9%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
6,428
Price
$62.18
Total Value
$399.71K
Shares Held After
1,041,667
% of Holdings
0.6%
Eton Pharmaceuticals, Inc. (ETON)
Krempa David — Chief Business Officer
Shares
19,679
Price
$31.47
Total Value
$619.37K
Shares Held After
25,249
% of Holdings
43.8%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
600
Price
$82.08
Total Value
$49.25K
Shares Held After
44,018
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
3,679
Price
$81.50
Total Value
$299.85K
Shares Held After
44,618
% of Holdings
7.6%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Faisal Ghiath — Director
Shares
122,174
Price
$0.41
Total Value
$50.01K
Shares Held After
125,574
% of Holdings
97.3%
Rein Therapeutics, Inc. (RNTX)
VON RICKENBACH JOSEF H — Director
Shares
23,190
Price
$1.06
Total Value
$24.47K
Shares Held After
58,014
% of Holdings
40.0%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
11,798
Price
$30.06
Total Value
$354.66K
Shares Held After
793
% of Holdings
93.7%
EXELIXIS, INC. (EXEL)
Aftab Dana — EVP, Research and Development
Shares
43,451
Price
$50.35
Total Value
$2.19M
Shares Held After
594,741
% of Holdings
6.8%
OCULAR THERAPEUTIX, INC (OCUL)
Nayak Sanjay — Chief Strategy Officer
Shares
1,858
Price
$8.20
Total Value
$15.24K
Shares Held After
328,795
% of Holdings
0.6%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
64,399
Price
$53.98
Total Value
$3.48M
Shares Held After
0
% of Holdings
100.0%
Revolution Medicines, Inc. (RVMD)
Mancini Anthony — Chief Global Commercialization Officer
Shares
421
Price
$154.82
Total Value
$65.18K
Shares Held After
54,400
% of Holdings
0.8%
Showing 351–400 of 1059 transactions (page 8 of 22)